<- Go Home
ChemoMetec A/S
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops XcytoMatic 30 cell counter and Xcyto 5, a versatile cell analyzer. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerod, Denmark.
Market Cap
DKK 13.8B
Volume
43.1K
Cash and Equivalents
DKK 341.8M
EBITDA
DKK 247.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
DKK 465.5M
Profit Margin
93.93%
52 Week High
DKK 804.00
52 Week Low
DKK 367.00
Dividend
0.88%
Price / Book Value
20.44
Price / Earnings
73.86
Price / Tangible Book Value
26.46
Enterprise Value
DKK 13.4B
Enterprise Value / EBITDA
54.22
Operating Income
DKK 236.5M
Return on Equity
30.10%
Return on Assets
19.65
Cash and Short Term Investments
DKK 341.8M
Debt
DKK 6.4M
Equity
DKK 673.4M
Revenue
DKK 495.6M
Unlevered FCF
DKK 145.2M
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium